
Patients can seek a licensed acupuncturist who may be able to help with hot flashes and other endocrine-related side effects, an expert said.

Patients can seek a licensed acupuncturist who may be able to help with hot flashes and other endocrine-related side effects, an expert said.

After fully recovering from non-Hodgkin lymphoma, I’m ready to embark on my next chapter in life doing the things I love with the people I love.

When faced with scanxiety, one technique Annie Bond uses is yoga breathing exercises to help “breathe through it and just get through the moment.”

I was told that after five years in remission, my cancer would be behind me. However, I was not told what life would be like after that milestone.

Contrary to past research, blood cancer survivors may have safe and successful pregnancies up to 10 years after an allogeneic stem cell transplant.

An analysis of more than 500 patients with advanced kidney cancer treated with Welireg broke down the rates of moderate to severe side effects.

Before having colon cancer, I struggled with self-esteem, but my diagnosis allowed me to love myself more.

A computer model may help predict which patients with breast cancer are more likely to experience neuropathy from taxane therapies.

After treatment for breast cancer ended, I was excited to move on, but the shadow of cancer continued following me.

Here are eight poems about my experience as a caregiver to my wife during her final days.

Actress Shannen Doherty has been open about her experience with breast cancer over the last few years as a way to help other people.

This year, I celebrate 10 years of being free from breast cancer. It’s hard to believe, but I am cherishing this milestone and plan to celebrate big.

Updated data has been reported evaluating efti and Keytruda in PD-L1 negative recurrent or metastatic head and neck squamous cell carcinoma.

Jenifer Keeler Smith, B.S.N., RN exemplified care for her patients, not just as a nurse, but as a caring friend.

One expert from the University of Colorado Cancer Center explains the multidisciplinary aspect of sarcoma care to maximize patients’ functioning.

Having a check-up appointment without receiving any type of scan is good, but also scares me.

From a TODAY contributor opening up about breast reconstruction surgery to Arizona rep. Raúl Grijalva completing cancer treatment, here’s what’s going on in the oncology space this week.

I was diagnosed with myeloma more than two decades ago and am lucky to have support throughout.

Results from a phase 2/3 study demonstrated that paxalisib led to a 3.8-month survival improvement in some patients with glioblastoma.

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma.

Side effects from multiple myeloma, such as six inches of collapsed vertebrae, have made me adjust my lifestyle, but I make the most of what I can.

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said.

Whenever I received bad news regarding my colorectal cancer, I felt like it was the end — until my therapist told me something that changed everything.

Dana Frost, a cancer survivor and grief advocate, said writing about survivors’ guilt and connecting with others feeling the same way was therapeutic.

During summer 2024, there have been many changes made in the non-small cell lung cancer and small cell lung cancer spaces. Here are four top news stories.

Although MDS didn’t leave physical scars, the invisible ones, like side effects from treatment, are ones that linger.

The TIL therapy OBX-115 ‘may have the potential to address’ an unmet need among patients with metastatic or locally advanced melanoma.

I spent a lot of time after my metastatic breast cancer diagnosis worrying of each experience would be my last. Then I had an epiphany.

The Food and Drug Administration granted a fast track designation to ADI-270, an off-the-shelf CAR-T cell therapy for clear cell renal cell carcinoma.

Perioperative treatment with BRAF and MEK inhibitors was found to benefit some patients with stage 3 and 4 melanoma, according to a recent study.